Velufenacin

CAS No. 1648737-78-3

Velufenacin( —— )

Catalog No. M37659 CAS No. 1648737-78-3

Velufenacin is an antagonist of muscarinic receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 107 In Stock
5MG 98 In Stock
10MG 159 In Stock
25MG 285 In Stock
50MG 383 In Stock
100MG 539 In Stock
200MG 710 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Velufenacin
  • Note
    Research use only, not for human use.
  • Brief Description
    Velufenacin is an antagonist of muscarinic receptor.
  • Description
    Velufenacin is a muscarinic receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1648737-78-3
  • Formula Weight
    362.83
  • Molecular Formula
    C19H20ClFN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (275.61 mM; Ultrasonic )
  • SMILES
    CN1CC[C@@H](COC(=O)Nc2ccccc2-c2ccc(F)c(Cl)c2)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 33, No. 4, 2019.
molnova catalog
related products
  • Metixene hydrochlori...

    Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively.

  • Darifenacin

    Darifenacin (UK-88525) is a muscarinic receptor M3 antagonist with anticonvulsant activity and can be used to study urinary incontinence and overactive bladder.

  • LY2033298

    LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.